ClariLight CL30

Molecular diagnostic testing with its high precision has revolutionized the way clinical and public health laboratories investigate disease, including oncology, infectious diseases, clinical chemistry, and clinical genetics. Nowadays, it is no longer available only to specialized centers and play an important role in the diagnosis of common infections seen in ambulatory practice. In settings with limited resources and a wide range of possible etiologies, molecular technologies offer an effective solution for infectious disease diagnostics, because of its agile, fast and flexible. CL30 helps health systems that routinely use molecular diagnostics will achieve economies of scale, maximize limited expertize and rapidly respond to new threats.